Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

ACROBiosystems TL1A (Biotinylated) : DR3 Inhibitor Screening ELISA Kit, 96 tests

Catalog No. NC3874542
Encompass_Preferred

Competition ELISA kit for screening inhibitors that block human TL1A binding to human DR3. The kit supplies biotinylated TL1A, recombinant human DR3, a control neutralizing antibody, and all necessary reagents in a 96-well format for early-stage inhibitor screening and QC testing.

  • Competition ELISA format for inhibitor screening.
  • Includes biotinylated TL1A and recombinant DR3 protein.
  • Provides a positive control neutralizing antibody and assay reagents.
  • Designed for 96-well screening and QC workflows.
  • Intended species: human.
  • Store unopened at 2-8 °C and follow component storage after opening.
  • No sensitivity or dynamic range specified on the product page.

Catalog No. NC3874542 Supplier ACROBiosystems Supplier No. EP16896TESTS
May include imposed supplier surcharges.
Add to Cart
Add to Cart

Competition ELISA kit for screening inhibitors that block human TL1A binding to human DR3. The kit supplies biotinylated TL1A, recombinant human DR3, a control neutralizing antibody, and all necessary reagents in a 96-well format for early-stage inhibitor screening and QC testing.

  • Competition ELISA format for inhibitor screening.
  • Includes biotinylated TL1A and recombinant DR3 protein.
  • Provides a positive control neutralizing antibody and assay reagents.
  • Designed for 96-well screening and QC workflows.
  • Intended species: human.
  • Store unopened at 2-8 °C and follow component storage after opening.
  • No sensitivity or dynamic range specified on the product page.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.